The European alternative that also does speech therapy — in native Portuguese.
Upheal is strong at AI session notes for mental health and is already in the EU. CarexBoost adds to that ground speech therapy beyond psychology, materials by condition, progress reports and native European Portuguese. The AI prepares; the professional always validates and decides.
If you already use Upheal, migration is simple and the data is always yours and your patient's. You gain speech therapy beyond psychology, materials by condition and progress reports — all in native Portuguese and EU-resident, GDPR compliant.
Highlighted rows = the CarexBoost advantage. The AI prepares; the professional always validates and decides.
Comparison verified in June 2026, based on public documentation.
| Capability | CarexBoost | Upheal |
|---|---|---|
| ★ AI material generation by condition × age | ||
| 🗣 Serves both psychology AND speech therapy | mental-health focus | |
| ★ AI progress reports (patient/family-facing, ~3 min) | notas de sessão com IA | |
| Structured notes + living plan per patient | ||
| Progress tracking / indicators | analytics | |
| Patient / family communication | ||
| Scheduling / practice management system | ||
| 🛡 EU-resident data, GDPR compliant | região UE | |
| 🛡 Native European Portuguese | multilingue (EN) | |
| Transparent pricing in euros | USD | |
| Clinician support — explicitly NOT a medical device |
On European soil, GDPR compliant. Clinical data is a special category of data and is hosted in the European Union, with access control.
Sim, ambos — psicólogos e terapeutas da fala. O Upheal foca-se num destes domínios; o CarexBoost cobre os dois na mesma plataforma.
CarexBoost: GDPR compliant, EU-resident, in native Portuguese, with AI that generates materials by condition and prepares progress reports.
No. The AI supports the professional, who always validates and decides. It is not a medical device.
Yes. We support the transition and the data is always yours and your patient's — no lock-in.
One connected platform
Before commercial launch · Early access · Data on European soil